These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats. Sari Y; Sreemantula SN; Lee MR; Choi DS J Mol Neurosci; 2013 Nov; 51(3):779-87. PubMed ID: 23893122 [TBL] [Abstract][Full Text] [Related]
7. Type 1 equilibrative nucleoside transporter (ENT1) regulates sex-specific ethanol drinking during disruption of circadian rhythms. Jia YF; Vadnie CA; Ho AM; Peyton L; Veldic M; Wininger K; Matveyenko A; Choi DS Addict Biol; 2020 Sep; 25(5):e12801. PubMed ID: 31267611 [TBL] [Abstract][Full Text] [Related]
8. Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum. Nam HW; Hinton DJ; Kang NY; Kim T; Lee MR; Oliveros A; Adams C; Ruby CL; Choi DS J Neurosci; 2013 Mar; 33(10):4329-38. PubMed ID: 23467349 [TBL] [Abstract][Full Text] [Related]
9. Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate. Chau P; Höifödt-Lidö H; Löf E; Söderpalm B; Ericson M Alcohol Clin Exp Res; 2010 Jan; 34(1):39-45. PubMed ID: 19860809 [TBL] [Abstract][Full Text] [Related]
10. Label-Free Neuroproteomics of the Hippocampal-Accumbal Circuit Reveals Deficits in Neurotransmitter and Neuropeptide Signaling in Mice Lacking Ethanol-Sensitive Adenosine Transporter. Oliveros A; Starski P; Lindberg D; Choi S; Heppelmann CJ; Dasari S; Choi DS J Proteome Res; 2017 Apr; 16(4):1445-1459. PubMed ID: 27998058 [TBL] [Abstract][Full Text] [Related]
11. Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. Nam HW; Lee MR; Hinton DJ; Choi DS Neurosci Lett; 2010 Aug; 479(3):277-81. PubMed ID: 20570605 [TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Das SC; Yamamoto BK; Hristov AM; Sari Y Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627 [TBL] [Abstract][Full Text] [Related]
13. Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice. Lee MR; Ruby CL; Hinton DJ; Choi S; Adams CA; Young Kang N; Choi DS Neuropsychopharmacology; 2013 Feb; 38(3):437-45. PubMed ID: 23032072 [TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. Blednov YA; Harris RA Int J Neuropsychopharmacol; 2008 Sep; 11(6):775-93. PubMed ID: 18377703 [TBL] [Abstract][Full Text] [Related]
16. Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum. Hinton DJ; Lee MR; Jang JS; Choi DS Brain Behav; 2014; 4(6):903-14. PubMed ID: 25365803 [TBL] [Abstract][Full Text] [Related]
17. Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Chen J; Nam HW; Lee MR; Hinton DJ; Choi S; Kim T; Kawamura T; Janak PH; Choi DS Behav Brain Res; 2010 Apr; 208(2):636-42. PubMed ID: 20085785 [TBL] [Abstract][Full Text] [Related]
18. Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Dahchour A; De Witte P; Bolo N; Nédélec JF; Muzet M; Durbin P; Macher JP Psychiatry Res; 1998 May; 82(2):107-14. PubMed ID: 9754453 [TBL] [Abstract][Full Text] [Related]
19. Acamprosate-responsive brain sites for suppression of ethanol intake and preference. Brager A; Prosser RA; Glass JD Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R1032-43. PubMed ID: 21697518 [TBL] [Abstract][Full Text] [Related]
20. Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. Olive MF; Nannini MA; Ou CJ; Koenig HN; Hodge CW Eur J Pharmacol; 2002 Feb; 437(1-2):55-61. PubMed ID: 11864639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]